Enhanced cleavage products of caspase-1, GSDMD, and IL-1β were observed in both imiquimod-induced psoriasis-like dermatitis (IIPLD) mouse epidermis and M5 (simulating psoriatic inflammatory challenge)-treated keratinocytes in vitro. This evidence concerns the gene CASP1 and skin disorder.